Compliance that clears hospital and payer procurement.

The moment your product touches a patient record, you inherit a set of obligations most software companies never face. Protected health information, or PHI, is some of the most tightly regulated data in the country. A name paired with a diagnosis, a claims file, a lab result, a prescription history — each of these carries legal weight the second it lands in your systems. Health buyers know this, and their procurement teams are trained to assume you are a risk until you prove otherwise.

HIPAA sits at the center of that pressure. If you create, receive, maintain, or transmit PHI on behalf of a covered entity, you are almost certainly a Business Associate, and the HIPAA Security and Privacy Rules apply to you directly. That means enforceable safeguards, signed Business Associate Agreements, and breach notification duties with real deadlines. Regulators can and do impose penalties that scale with how careless the conduct was, and those figures climb quickly for a small company.

Then there is the cost of getting it wrong. Healthcare breaches are consistently the most expensive of any sector, often running into millions of dollars per incident once you count investigation, notification, credit monitoring, legal exposure, and lost contracts. A hospital or a national payer will not risk that exposure on an unproven vendor. Their procurement process exists specifically to filter out suppliers who cannot document how they guard PHI. If you cannot answer the security questionnaire with evidence, you do not reach the next stage, and the deal stalls before it starts.

Pharma adds its own layers. Clinical trial data, adverse event reporting, and manufacturing systems bring validation expectations and regulated recordkeeping on top of privacy law. Whether you build digital health software, a telehealth platform, a diagnostics tool, or a research data pipeline, the pattern is the same: the buyer treats compliance as the price of admission, and the burden of proof sits with you.

The timing pressure is what surprises most founders. Procurement rarely warns you in advance. A questionnaire arrives midway through a promising sales cycle, and it asks for documents that take months to produce honestly. Teams that wait until a buyer asks find themselves trying to compress a genuine security program into the few weeks before a contract deadline, which is neither convincing to the buyer nor safe for the patients whose data you hold. The companies that win these deals treat compliance as groundwork laid before the questionnaire lands, not a scramble triggered by it.

Health-tech founders often ask us to pick a single framework and be done. The honest answer is that healthcare usually calls for a stack, but the order matters as much as the list. Sequencing it well saves you months and avoids paying twice for overlapping work.

Start with a HIPAA assessment. HIPAA is the law that governs PHI, so it is the floor, not the ceiling. Before anything else, we assess your obligations, confirm whether you are a Business Associate, and measure your safeguards against the HIPAA Security Rule. This tells you where real gaps sit and gives you a defensible position with regulators and with any covered entity that asks.

Add SOC 2 for the platform. HIPAA tells a buyer you meet a legal standard. SOC 2 tells them an independent CPA firm examined the controls behind your platform and reported on how they operate. Hospital and payer security teams read a SOC 2 report closely, because it describes your access control, change management, monitoring, and vendor oversight in detail rather than asserting compliance. Pairing HIPAA and SOC 2 for healthcare is the combination most enterprise health buyers actually want to see.

Then consider ISO 27001. Once HIPAA and SOC 2 are in hand, ISO 27001 gives you a recognized certification that international customers and larger partners often request. Much of the underlying control work overlaps with SOC 2, so building it third means you reuse evidence rather than starting over.

One more thing worth naming plainly: some healthcare buyers ask specifically for HITRUST, a certifiable framework built around healthcare data. It exists as a genuine market ask, and if a specific customer contract names it, we will tell you honestly. For most companies, though, a clean HIPAA assessment plus a SOC 2 report answers the question that procurement is really asking, and you can add further certifications when a concrete deal requires them.

The reason we push back on framework stacking is cost discipline. Every framework you add carries real work: policies to write, controls to run, evidence to collect, and an examination to sit through. Chasing certifications a buyer has not asked for burns cash and engineering time you could spend on the product. Our job is to match the program to the deals in front of you, then leave the structure ready to extend the day a new requirement is real. That way you spend on compliance that actually moves a contract, and you keep the option to grow the program without rebuilding it.

Generic security advice misses the risks that actually sink healthcare vendors. When we scope your program, we trace the parts of your operation that regulators and buyers scrutinize hardest.

ePHI flows. The first question is always where electronic PHI enters, where it rests, and where it leaves. We map every path — ingestion from a provider, storage in your database, backups, logs, analytics pipelines, and any export to a third party. PHI that leaks into a debug log or an unencrypted backup is one of the most common findings, and it is exactly what a careful auditor looks for. Once the map is complete, encryption in transit and at rest stops being a checkbox and becomes something you can point to on every leg of the journey.

Business Associate chains. You are rarely the last link. Your cloud host, your email provider, your analytics vendor, and your subprocessors may all touch PHI, which makes them your subcontractors under HIPAA. Every one of those relationships needs a Business Associate Agreement and real oversight. A weak vendor several steps down the chain becomes your breach, so we examine the whole chain rather than just your front door.

Medical device and telehealth data. Connected devices, remote monitoring tools, and telehealth video carry PHI across networks you do not fully control. Session data, device telemetry, and recordings each need encryption in transit and at rest, plus clear retention rules. We look at how that data moves between the patient, the device, and your platform.

Research and clinical data. Trial data, genomic records, and de-identified datasets each carry their own rules. De-identification that is not done to standard can re-identify a patient and turn a research dataset back into regulated PHI. For pharma and research clients, we check that the boundary between identified and de-identified data actually holds.

Access and the minimum-necessary principle. HIPAA expects you to limit PHI access to what each role genuinely needs. In practice, fast-growing teams over-provision: an engineer keeps production access from a debugging session two years ago, or a support agent can read full records when a masked view would do. We examine who can reach PHI, why, and whether you can prove that access is reviewed. Loose access is both a common audit finding and one of the most likely routes to a breach.

Breach readiness. A breach procedure that has never been exercised tends to fail under pressure, and HIPAA sets firm deadlines for notifying affected individuals and regulators. We look at whether your team can actually detect an incident, scope which records were involved, and notify within the required window. Knowing you can respond is worth far more than a policy document nobody has read since it was written.

The following is an anonymized, illustrative composite drawn from the kinds of engagements we see. It is not a specific client, and no real names or figures are involved.

Picture a telehealth startup, 40 people, growing fast on the back of direct-to-consumer visits. A regional payer offers to route covered members to the platform, a deal that would roughly double revenue. Procurement sends over a security questionnaire, and two lines stop the founders cold: the payer wants evidence of HIPAA compliance and a current SOC 2 report before they will sign. The startup has strong engineering and good intentions, but no formal assessment and no report to hand over. The deal is frozen on a document they do not have.

We start with the HIPAA assessment, because the payer is a covered entity and the platform is squarely a Business Associate. The gap review surfaces the usual suspects: PHI landing in application logs, two subprocessors without signed Business Associate Agreements, and a breach notification procedure that exists on paper but has never been tested. The team fixes each one over several weeks with our support.

From there, we map those same controls to the SOC 2 criteria and run a Type I examination to give the payer something concrete quickly, with a Type II scheduled to cover the following operating period. Because the HIPAA remediation already stood up most of what SOC 2 tests, the readiness step is short rather than a second project from scratch. The startup hands procurement a HIPAA assessment and a CPA-signed SOC 2 report, answers the questionnaire with evidence instead of promises, and clears the security review.

The deal moves forward, and the founders now have a control set they can extend to ISO 27001 the next time an international partner asks. The point is not that compliance closed the sale on its own. It is that the absence of HIPAA and SOC 2 would have killed it before anyone talked price, and that a well-sequenced program turned a procurement blocker into a repeatable asset. Every future health buyer will ask the same two questions, and the startup can now answer both on day one.